메뉴 건너뛰기




Volumn 204, Issue 2, 2008, Pages 89-96

Immunohistochemical expression of angiogenic cytokines in childhood Hodgkin lymphoma

Author keywords

Childhood Hodgkin's lymphoma; Gelatinases; Microvessel density; TIMP 1; VEGF

Indexed keywords

ANGIOGENIC FACTOR; BLEOMYCIN; CD31 ANTIGEN; CYCLOPHOSPHAMIDE; CYTOKINE; DACARBAZINE; DOXORUBICIN; GELATINASE A; GELATINASE B; MONOCLONAL ANTIBODY; PARAFFIN; PREDNISOLONE; PROCARBAZINE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN; VINBLASTINE; VINCRISTINE;

EID: 39149130691     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2007.11.005     Document Type: Article
Times cited : (11)

References (37)
  • 1
    • 0141995781 scopus 로고    scopus 로고
    • Re: Doussis-Anagnostopoulou et al. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease
    • Agarwal B., and Naresh K.N. Re: Doussis-Anagnostopoulou et al. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease. J. Pathol. 201 (2003) 334-335
    • (2003) J. Pathol. , vol.201 , pp. 334-335
    • Agarwal, B.1    Naresh, K.N.2
  • 3
    • 0034615550 scopus 로고    scopus 로고
    • Tissue inhibitors of metalloproteinases: evolution, structure and function
    • Brew K., Dinakarpandian D., and Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta 1477 (2000) 267-283
    • (2000) Biochim. Biophys. Acta , vol.1477 , pp. 267-283
    • Brew, K.1    Dinakarpandian, D.2    Nagase, H.3
  • 4
    • 0035500490 scopus 로고    scopus 로고
    • The many faces of metalloproteinases: cell growth, invasion, angiogenesis and metastasis
    • Chang C., and Werb Z. The many faces of metalloproteinases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol. 11 (2001) S37-S43
    • (2001) Trends Cell Biol. , vol.11
    • Chang, C.1    Werb, Z.2
  • 6
    • 0030498734 scopus 로고    scopus 로고
    • Angiogenesis and metastasis
    • Ellis L.M., and Fidler L.J. Angiogenesis and metastasis. Eur. J. Cancer 32A (1996) 2413-2422
    • (1996) Eur. J. Cancer , vol.32 A , pp. 2413-2422
    • Ellis, L.M.1    Fidler, L.J.2
  • 8
    • 0030764802 scopus 로고    scopus 로고
    • Expression of vascular endothelial growth factor in lymphomas and Castleman's disease
    • Foss H.D., Araujo I., Demel G., Klotzbach H., Hummel M., and Stein H. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. J. Pathol. 183 (1997) 44-50
    • (1997) J. Pathol. , vol.183 , pp. 44-50
    • Foss, H.D.1    Araujo, I.2    Demel, G.3    Klotzbach, H.4    Hummel, M.5    Stein, H.6
  • 9
    • 0030028043 scopus 로고    scopus 로고
    • Matrix metalloproteinases in immunity
    • Goetzl E.J., Banda M.J., and Leppert D. Matrix metalloproteinases in immunity. J. Immunol. 156 (1996) 1-4
    • (1996) J. Immunol. , vol.156 , pp. 1-4
    • Goetzl, E.J.1    Banda, M.J.2    Leppert, D.3
  • 10
    • 0038391043 scopus 로고    scopus 로고
    • Mechanisms and its regulation of tumor-induced angiogenesis
    • Gupta K.M., and Quin R.Y. Mechanisms and its regulation of tumor-induced angiogenesis. World J. Gastroenterol. 9 (2003) 1144-1155
    • (2003) World J. Gastroenterol. , vol.9 , pp. 1144-1155
    • Gupta, K.M.1    Quin, R.Y.2
  • 11
    • 0346655231 scopus 로고    scopus 로고
    • From the cradle to the clinic: VEGF in developmental, physiological, and pathological angiogenesis
    • Harry L.E., and Paleolog E.M. From the cradle to the clinic: VEGF in developmental, physiological, and pathological angiogenesis. Birth Defects Res. C Embryo Today 69 (2003) 363-374
    • (2003) Birth Defects Res. C Embryo Today , vol.69 , pp. 363-374
    • Harry, L.E.1    Paleolog, E.M.2
  • 13
    • 0037294520 scopus 로고    scopus 로고
    • Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma
    • Ho C.L., Sheu L.F., and Li C.Y. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma. Ann. Diagn. Pathol. 7 (2003) 1-8
    • (2003) Ann. Diagn. Pathol. , vol.7 , pp. 1-8
    • Ho, C.L.1    Sheu, L.F.2    Li, C.Y.3
  • 16
    • 3843150503 scopus 로고    scopus 로고
    • Vascular endothelial growth factor in esophageal cancer
    • Kleespies A., Guba M., Jauch K.W., and Bruns C.J. Vascular endothelial growth factor in esophageal cancer. J. Surg. Oncol. 87 (2004) 95-104
    • (2004) J. Surg. Oncol. , vol.87 , pp. 95-104
    • Kleespies, A.1    Guba, M.2    Jauch, K.W.3    Bruns, C.J.4
  • 17
    • 0027300274 scopus 로고
    • Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas
    • Kossakowska A.E., Urbanski S.J., Watson A., Hayden L.J., and Edwards D.R. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncol. Res. 5 (1993) 19-28
    • (1993) Oncol. Res. , vol.5 , pp. 19-28
    • Kossakowska, A.E.1    Urbanski, S.J.2    Watson, A.3    Hayden, L.J.4    Edwards, D.R.5
  • 18
    • 0034485309 scopus 로고    scopus 로고
    • Matrix metalloproteinases and their tissue inhibitors-expression, role and regulation in human malignant non-Hodgkin's lymphomas
    • Kossakowska A.E., Urbanski S.J., and Janowska-Wieczorek A. Matrix metalloproteinases and their tissue inhibitors-expression, role and regulation in human malignant non-Hodgkin's lymphomas. Leukemia Lymphoma 39 (2000) 485-493
    • (2000) Leukemia Lymphoma , vol.39 , pp. 485-493
    • Kossakowska, A.E.1    Urbanski, S.J.2    Janowska-Wieczorek, A.3
  • 19
    • 18744383031 scopus 로고    scopus 로고
    • Diverse role of MMP-2 and MMP-9 in the clinicopathological behavior of Hodgkin's lymphoma
    • Kuittinen O., Soini Y., and Turpeenniemi-Huajen T. Diverse role of MMP-2 and MMP-9 in the clinicopathological behavior of Hodgkin's lymphoma. Eur. J. Haematol. 69 (2002) 205-212
    • (2002) Eur. J. Haematol. , vol.69 , pp. 205-212
    • Kuittinen, O.1    Soini, Y.2    Turpeenniemi-Huajen, T.3
  • 20
    • 30644476010 scopus 로고    scopus 로고
    • Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PDEGF) in classical Hodgkin lymphoma (HL)
    • Mainou-Fowler T., Angus B., Miller S., Proctor S.J., Taylor P.R., and Wood K.M. Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PDEGF) in classical Hodgkin lymphoma (HL). Leukemia Lymphoma 47 (2006) 223-230
    • (2006) Leukemia Lymphoma , vol.47 , pp. 223-230
    • Mainou-Fowler, T.1    Angus, B.2    Miller, S.3    Proctor, S.J.4    Taylor, P.R.5    Wood, K.M.6
  • 22
  • 23
    • 0036095975 scopus 로고    scopus 로고
    • Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells
    • Oelmann E., Herbst H., Zuhlsdorf M., Albrecht O., Nolte A., Schmitmann C., Manzke O., Diehl V., Stein H., and Berdel W.E. Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells. Blood 99 (2002) 258-267
    • (2002) Blood , vol.99 , pp. 258-267
    • Oelmann, E.1    Herbst, H.2    Zuhlsdorf, M.3    Albrecht, O.4    Nolte, A.5    Schmitmann, C.6    Manzke, O.7    Diehl, V.8    Stein, H.9    Berdel, W.E.10
  • 24
    • 0036095975 scopus 로고    scopus 로고
    • Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells
    • Oelmann E., Oelmann E., Herbst H., Zühlsdorf M., Albrecht O., Nolte A., Schmitmann C., Manzke O., Diehl V., Stein H., and Berdel W.E. Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells. Blood 99 (2002) 258-267
    • (2002) Blood , vol.99 , pp. 258-267
    • Oelmann, E.1    Oelmann, E.2    Herbst, H.3    Zühlsdorf, M.4    Albrecht, O.5    Nolte, A.6    Schmitmann, C.7    Manzke, O.8    Diehl, V.9    Stein, H.10    Berdel, W.E.11
  • 26
    • 0742269390 scopus 로고    scopus 로고
    • Determination of vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas and the role of overexpression in leiomyosarcoma
    • Potti A., Ganti A.K., Tendulkar K., Sholes K., Chitajallu S., Koch M., and Kargas S. Determination of vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas and the role of overexpression in leiomyosarcoma. J. Cancer Res. Clin. Oncol. 130 (2004) 52-56
    • (2004) J. Cancer Res. Clin. Oncol. , vol.130 , pp. 52-56
    • Potti, A.1    Ganti, A.K.2    Tendulkar, K.3    Sholes, K.4    Chitajallu, S.5    Koch, M.6    Kargas, S.7
  • 27
    • 24044459285 scopus 로고    scopus 로고
    • Matrix metalloproteinases and angiogenesis
    • Rundhaug J.E. Matrix metalloproteinases and angiogenesis. J. Cell Mol. Med. 9 (2005) 267-285
    • (2005) J. Cell Mol. Med. , vol.9 , pp. 267-285
    • Rundhaug, J.E.1
  • 28
    • 18244390735 scopus 로고    scopus 로고
    • Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein
    • Ruokolainen H., Paakko P., and Turpeenniemi-Hujanen T. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein. Clin. Cancer Res. 11 (2005) 3257-3264
    • (2005) Clin. Cancer Res. , vol.11 , pp. 3257-3264
    • Ruokolainen, H.1    Paakko, P.2    Turpeenniemi-Hujanen, T.3
  • 30
    • 0030829035 scopus 로고    scopus 로고
    • Enhanced expression of endothelial growth factor in metastatic melanoma
    • Salven P., Heikkita P., and Joensuu H. Enhanced expression of endothelial growth factor in metastatic melanoma. Br. J. Cancer 76 (1997) 930-934
    • (1997) Br. J. Cancer , vol.76 , pp. 930-934
    • Salven, P.1    Heikkita, P.2    Joensuu, H.3
  • 31
    • 0034892043 scopus 로고    scopus 로고
    • Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer
    • Schmalfeldt B., Prechtel D., Harting K., Spathe K., Rutke S., Konik E., Fridman R., Berger U., Schmitt M., Kuhn W., and Lengyel E. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin. Cancer Res. 7 (2001) 2396-2404
    • (2001) Clin. Cancer Res. , vol.7 , pp. 2396-2404
    • Schmalfeldt, B.1    Prechtel, D.2    Harting, K.3    Spathe, K.4    Rutke, S.5    Konik, E.6    Fridman, R.7    Berger, U.8    Schmitt, M.9    Kuhn, W.10    Lengyel, E.11
  • 32
    • 1842415455 scopus 로고    scopus 로고
    • Vessel counts and expression of vascular endothelial growth factor as prognostic factor in node-negative colon cancer
    • Takahashi Y., Tucker S.L., Kitadai Y., Koura A.N., Bucana C.D., Cleary K.R., and Ellis L.M. Vessel counts and expression of vascular endothelial growth factor as prognostic factor in node-negative colon cancer. Arch. Surg. 132 (1997) 541-546
    • (1997) Arch. Surg. , vol.132 , pp. 541-546
    • Takahashi, Y.1    Tucker, S.L.2    Kitadai, Y.3    Koura, A.N.4    Bucana, C.D.5    Cleary, K.R.6    Ellis, L.M.7
  • 34
    • 15244348390 scopus 로고    scopus 로고
    • Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers
    • Turpeenniemi-Hujanen T. Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie 87 (2005) 287-297
    • (2005) Biochimie , vol.87 , pp. 287-297
    • Turpeenniemi-Hujanen, T.1
  • 35
    • 0031982331 scopus 로고    scopus 로고
    • In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis
    • Uchida S., Shimada Y., Watanabe G., Tanaka H., Shibagaki I., Miyahara T., Ishigami S., and Imamura M. In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis. Br. J. Cancer 77 (1998) 1704-1709
    • (1998) Br. J. Cancer , vol.77 , pp. 1704-1709
    • Uchida, S.1    Shimada, Y.2    Watanabe, G.3    Tanaka, H.4    Shibagaki, I.5    Miyahara, T.6    Ishigami, S.7    Imamura, M.8
  • 37
    • 0033134764 scopus 로고    scopus 로고
    • Bone marrow neovascularization, plasma cell angiogenic potential and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma
    • Vacca A., Ribatti D., Presta M., Minischetti M., Iurlaro M., and Ria R. Bone marrow neovascularization, plasma cell angiogenic potential and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 9 (1999) 3064-3073
    • (1999) Blood , vol.9 , pp. 3064-3073
    • Vacca, A.1    Ribatti, D.2    Presta, M.3    Minischetti, M.4    Iurlaro, M.5    Ria, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.